Gilead Sciences (GILD) Stock Price & AI Analysis

NASDAQ
USA

$92.96

$1.12
(1.22%)

Subscribe to get
AI Score

Gilead Sciences Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm’s primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm’s primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences | Latest news

GILD vs. ALNY: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably...

Zacks - 5 hours ago

150 Years of See and Be Seen at Paris’s Palais Garner Opera House

The Palais Garnier in Paris is among the world’s oldest theaters that still functions more or less...

New York Times - 6 hours ago

Is Gilead Sciences (GILD) Among Billionaire Steve Cohen’s Top Stock Picks?

We recently published a list of Billionaire Steve Cohen’s Top 15 Stock Picks. In this article, we...

Insider Monkey - 2 days ago

The Gilded Age of Trump Begins Now

Sign up for Trump’s Return Updated at 4:55 p.m. ET on January 20, 2025 Eight years ago, with his “American carnage” speech, Donald Trump delivered what...

The Atlantic - 3 days ago

Welcome to America's new Gilded Age

Trump’s MAGA nostalgia for an earlier age of American power and prosperity was solidified by the president’s praise for William McKinley, ostensibly for the 25th president’s support for tariffs ...

Religion News Service - 1 day ago

New Trump power dynamic ushers in a Gilded Age in D.C.

President Trump's made-for-TV inauguration gave a taste of a blossoming new Gilded Age in...

Axios - 1 day ago

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Hennion & Walsh Asset...

Hennion & Walsh Asset Management Inc. reduced its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 33.4% during the 4th quarter, according to its most recent Form 13F ...

ETF DAILY NEWS - 4 days ago

Ivanka & Melania Trump STUN in gowns at Inaugural Ball... there's a clear winner

AS the Trump ladies took to the floor at the inauguration ball, onlookers were stunned but one woman...

The US Sun - 2 days ago

Why Gilead Sciences (GILD) Outpaced the Stock Market Today

The latest trading session saw Gilead Sciences (GILD) ending at $92.96, denoting a +1.22% adjustment...

Zacks - 2 days ago

In Trump’s new Gilded Age, democracy is being deconstructed [letter]

I believe that if President Donald Trump has his way, America will return to the Gilded Age, which...

Lancaster Online - 12 hours ago